Rentokil Initial (OTCMKTS:RTOKY) Price Target Cut to GBX 550 by Deutsche Bank Aktiengesellschaft Analysts
Rentokil Initial (OTCMKTS:RTOKY – Get Review) saw its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from 630 GBX ($8.25) to 550 GBX ($7.21) in a report on Friday, reports The Fly.
Other analysts have also recently published research reports on the company. Zacks Investment Research upgraded Rentokil Initial from a “hold” rating to a “sell” rating in a Tuesday, February 15 research report. Berenberg Bank upgraded Rentokil Initial from a “hold” rating to a “buy” rating in a Friday, January 21 research note. Finally, Citigroup upgraded Rentokil Initial from a “neutral” rating to a “buy” rating in a Thursday, January 20 research report. One research analyst rated the stock with a sell rating, one gave the stock a hold rating, and eight gave the stock a buy rating. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $297.00.
Shares of OTCMKTS:RTOKY traded down $0.37 during the midday session on Friday, hitting $31.07. 54,965 shares of the company have traded, compared to its average volume of 55,216. The company has a current ratio of 1.02, a quick ratio of 0.97 and a debt ratio of 1.13. Rentokil Initial has a one-year minimum of $29.45 and a one-year maximum of $43.69. The stock has a 50-day moving average of $35.12 and a 200-day moving average of $38.90.
About Rentokil Initial (Get an assessment)
Rentokil Initial Plc is committed to providing business support services. The company through its products and services protects people against the dangers of diseases transmitted by pests and the risks of poor hygiene. It operates through the following geographical segments: France, Benelux, Germany, Southern Europe and Latin America.
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Rentokil Initial right now?
Before you consider Rentokil Initial, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Rentokil Initial didn’t make the list.
Although Rentokil Initial currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here